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Summary
The prevalence of idiopathic nephrolithiasis is increasing in
rich countries. Dietary manipulation could contribute to the
prevention of both its first appearance and the recurrence of
the disease. The target  of dietary treatment is to decrease the
“urinary lithogenic risk factors” such as low urine volume, hy-
percalciuria, hyperoxaluria, hyperuricosuria, hyperphospha-
turia, hypocitraturia, hypomagnesuria and excessively alka-
line or acid urinary pH. Due to the lack of randomized con-
trolled trials focused on this problem, there is not ample evi-
dence to confidently recommend dietary changes. Despite
this, numerous recent and past experiences support modifica-
tion of diet as having a primary role in the prevention of
nephrolithiasis. In particular, it is recommended to limit ani-
mal protein and salt intake, to consume milk and derivatives
in amounts corresponding to calcium intake of about 1200
mg/day and to assume fiber (40 g/day),  vegetables and fruit
daily avoiding foods with high oxalate content. Furthermore,
vitamin C intake not exceeding 1500 mg/day plays a protective
role as well as avoiding vitamin B6 deficiency and abstaining,
if possible, from vitamin D supplements. Lastly, it is recom-
mended to drink enough water to bring the urinary volume up
to at least 2 L/day and, as much as possible, to use fresh or
frozen products rather than prepacked or precooked foods
which are often too rich in sodium chloride.
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Introduction
Like other “well-being diseases” such as obesity, hypertension,
atherosclerosis, myocardial infarction and type 2 diabetes,
nephrolithiasis is progressively on the increase in rich countries
(1, 2), being now a very common condition affecting in the USA
10% of the population (3) with an economic burden of about 2
billion dollars per annum (4). 
Only in extremely rare cases it is a result of hereditary or well-
defined acquired diseases such as cystinuria, congenital hy-
peroxaluria, primary hyperparathyroidism, renal tubular acido-
sis, infections or anatomical alterations of the urinary tract (sec-
ondary nephrolithiasis), all conditions in which diet plays a mar-
ginal role. In the majority of cases stone disease strikes other-
wise healthy people (idiopathic nephrolithiasis) and appears to
be closely correlated to life style and diet (5).
Although only few well conducted randomized-control trials
have been performed so far, large cohort studies, such as the
Nurses’ Health Study (6, 7) and the Health Professionals Fol-
low-up Study (8, 9), have provided, together with various ex-
perimental studies, evidence which is consistent enough to
state that appropriate dietary manipulations can successfully
prevent both the first appearance and the recurrences of idio-
pathic nephrolithiasis. Hence, it is extremely important that not
just the specialist, but the general practitioner also should be
fully aware of the primary role of diet in the management of this
condition.
In 90% of cases of idiopathic nephrolithiasis, the stones are
made of calcium oxalate, often associated with variable traces
of calcium phosphate and, occasionally, uric acid; in 10% they
are made of pure uric acid (10). Nutrition has a direct impact on
the mechanisms involved in the genesis of urinary calculi (11).
The first step in the genesis of a kidney stone is the formation
of crystal nuclei. This event occurs when the concentration of a
salt exceed the solubility limit (supersaturation). Sometimes
this is also accompanied by a deficit in the protective sub-
stances known as crystallization inhibitors, e.g. citrate and
magnesium. By the term “urinary stone risk factors” (12), we
refer to a series of conditions which, all together, either pro-
mote or prevent the crystallization of a salt.
For calcium oxalate stones, the most widely recognized urinary
stone risk factors are low urine volume (< 2 L/day), hypercal-
ciuria (> 250 mg/day [6.25 mmol]), hyperoxaluria (> 45 mg/day
[0.5 mmol]), hyperuricosuria (> 700 mg/day [0.24 mmol]),
hypocitraturia (< 320 mg/day [1.7 mmol]), and hypomagnesuria
(< 60 mg/day [2.5 mmol])
For calcium phosphate stones, important factors are hyper-
phosphaturia (> 1100 mg/day [35.6 mmol]) and an excessively
alkaline urine pH (> 7.0) along with low urine volume, hypercal-
ciuria and hypocitraturia. 
For uric acid stones, favoring factors are low urine volume, hy-
peruricosuria and an excessively acid urine pH (< 5.5).
The existence of a genetic substratum in idiopathic stone dis-
ease cannot be overlooked (13), but diet undoubtedly has a di-
rect effect on all of the above urinary stone risk factors as well
as on the subsequent pathogenic steps.
The role of water and other fluids
The urine volume plays a huge role on the saturation of litho-
genic salts. We used the computer program Equil (14) to simu-
late the changes of the relative saturation for calcium oxalate,
calcium phosphate and uric acid when the urine volume in-
creases from 0.5 to 3.0 L/day, while keeping constant all the
other urinary parameters involved in the calculation of satura-
tion point. By this way, we saw that with diuresis below 1 L/day,
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even the urine of a normal subject reaches extremely high su-
persaturation levels, certainly high enough to promote sponta-
neous crystallization of the lithogenic salts. If, on the other
hand, the volume is maintained over 2.5 L/day, the urine be-
comes undersaturated for calcium phosphate and uric acid and
only slightly supersaturated for calcium oxalate, making spon-
taneous crystallization impossible. Given that, in the context of
these physiological variations in diuresis, ion excretion is large-
ly independent of urine volume, this example simulates very
closely what actually happens when water intake is high.
It could be argued that the increase in urine volume would di-
lute the crystallization inhibitors, and thus offset its positive ef-
fects on lithogenic salts. However, observations made on both
normal subjects and idiopathic calcium stone formers dispel
this argument because (a) the level of supersaturation required
to cause spontaneous calcium oxalate nucleation in diluted
urine is greater than that required in the non diluted urine of the
same subjects (15); (b) the oxalate amount one has to add to
the diluted urine to produce calcium oxalate crystallization in
vitro is higher than that required in non diluted urine (16), and
(c) the inhibitory power of the macromolecules extracted from
non diluted urine is not quantitatively different from that of the
macromolecules extracted from non diluted urine (16). Finally,
studies in progress in our laboratory in both normal subjects
and calcium stone formers show that the number and quantity
of calcium oxalate crystals and crystalline aggregates pro-
duced with an oxalate load in vitro are markedly lower in dilut-
ed urine than in non diluted urine. 
Increased urine volume might exert its antilithogenic effect also
by reducing the transit time of renal intratubular fluids, thereby
favoring the expulsion of the crystals (17) and inhibiting the for-
mation of Randall’s plaques (18).
By converse, low urine volume is a lithogenic risk factor (19),
as shown by cohort studies in which subjects consuming less
than 1.5 liters of fluid per day had about a 50% increase in inci-
dence of kidney stone as compared to those consuming over
2.5 L of fluid per day (6-9).
Two trials are to be quoted about the beneficial effects of wa-
ter. The first (20) showed that the incidence of kidney stones in
a community living in warm climate and that had been educat-
ed to drink more water was ten times lower than that detected
in a matched community that had not been educated to do so;
the second (21), a randomized-controlled study, showed that
the calcium stone formers who increased their water intake in
order to increase their urine volume, from approx. 1 to approx.
2 liters per day, during 5 years had a recurrence rate of 12 %
as compared to 27% who had not changed their water intake.
Whilst there is no doubt that the quantity of water consumed is
important for both the primary and secondary prevention (re-
currences) of stone formation, it is still controversial whether
hard waters, i.e. rich in calcium and other minerals, are as ef-
fective as light waters (22).
As to the fluids other than water, some reports (23-31) suggest
that coffee, tea, beer, wine, orange juice, lemon juice and
blackcurrant juice can reduce the risk of stone formation, while
grapefruit juice, apple juice, soda and cola drinks increase it.
In conclusion, the evidence currently available shows that a
water intake sufficient to increase urine volume to at least 2
liters/day exerts an antilithogenic effect. Some fluid such as or-
ange juice or lemon juice might elicit some additional benefits. 
The role of proteins
As regards the effect of animal proteins, the findings from co-
hort studies are conflicting. The male subjects from the Health
Professionals Follow-up Study, whose intake of animal proteins
exceeded 75 g/day (upper quintile) had the highest risk of
forming stones (8,9) a response not shared by the females of
the Nurses’ Health Study (6). Indeed, in younger women, ani-
mal proteins exerted, if anything, a moderately protective ac-
tion (7). However, in a nation-wide survey in the UK (32), vege-
tarians showed a prevalence of urinary stone formation about
half that found in a sample taken from the general population
matched for age, sex and social class.
As to the urinary stone risk factors, most studies found that ani-
mal proteins (meat, fish and poultry) have an unfavorable effect
because they increase calciuria, uricuria, and phosphaturia,
while reducing citrate and urine pH (33). It has been estimated
that in normal subjects for every 25 g increase in dietary animal
protein, urinary calcium rises 32 mg (34). When overweight
subjects (35) increased their habitual protein intake, from about
90 g/day to approximately 170 g/day of largely animal proteins
(Atkins diet) for 6 weeks, their calciuria rose by about 90
mg/day (2.25 mmol), uricuria by about 130 mg/day (1.3 mmol),
phosphaturia by about 620 mg/day (20.2 mmol), while their cit-
raturia decreased by about 180 mg/day (0.9 mmol) and the
urine pH from 6.09 to 5.67. Some studies have reported that
animal proteins also produce an increase in oxaluria (36). With
urine volumes kept unchanged, the final outcome of a high ani-
mal protein intake is an increase in supersaturation for both
calcium oxalate and uric acid. Even more relevant is the fact
that, at parity of animal protein load, these urinary effects seem
more marked in stone formers, as though these subjects had a
sort of genetic hypersensitivity towards such foods (37).
The mechanisms by which animal proteins produce these ef-
fects are only partially understood. The increases in uricuria
and phosphaturia are directly related to the high purine and
phosphorus content of animal proteins. The increase in calci-
uria and the reduction in citraturia and urine pH are mainly at-
tributed to the high content of sulphurated amino acids (methio-
nine and cysteine) which, by producing high quantities of hidro-
genions, cause a metabolic shift towards a state of subclinical
acidosis (38). The mechanism of the increased oxaluria is less
clear. According to a widely quoted view, the oxalate precur-
sors present in animal proteins, such as the amino acids tyro-
sine, tryptophan, phenylalanine and hydroxyproline, cause an
increase in endogenous oxalate production (39).
It is important to point out that the vegetable proteins produce
urinary effects different from those of the animal proteins. An
experiment was carried out on normal subjects in which 75
g/day of exclusively animal proteins were first replaced by an
equal quantity of mixed ovo-vegetable proteins, then by exclu-
sively vegetable proteins (40). The data show that with an ex-
clusively vegetarian intake the urine contains less calcium, less
phosphorus, more oxalate, more citrate and fewer acids. These
differences may be explained by the different content of
purines, oxalates, sulfates and fibers. On the whole, these data
clearly indicate that vegetable proteins have a much lower lith-
ogenic potential, particularly with regard to uric acid stone dis-
ease.
Only two randomized-controlled trials have been carried out to
evaluate the hypothesis that a reduction in animal proteins
could prevent recurrences in idiopathic calcium stone disease.
One showed that after a period of over 4 years the group treat-
ed with low animal protein and high fiber diet had a higher re-
currence rate (12/50 = 24%) than the control group (2/49 = 4%)
treated with high fluid and a usual calcium intake (41). It should
be, however, pointed out that this trial had several major limita-
tions: a) the water intake in the control group was higher; b)
compliance with the low protein diet was actually very poor; c)
there may have been differences between the two groups as
regards the intake of dietary calcium and fiber, both of which
influence stone formation. 
The other trial compared a low calcium diet (i.e., free of milk
and dairy products) with a low-animal protein, low-salt and nor-
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mal calcium diet (42). After 5 years, the recurrence risk in the
first group was higher (23/60 = 38%) than in the other group
(12/60 = 20%), but it should be pointed out that, in this experi-
ment, it was not possible to distinguish the protective effect of
the low animal protein intake from that due to the higher calci-
um and lower salt intake.
All in all, the aforementioned dietary studies favor the view that
subjects at risk for calcium or uric acid stone disease should
avoid consuming large quantities of animal proteins.
The role of carbohydrates
An increased intake of sucrose was found associated with
stone risk in women (6, 7), but not in men (9).
It is well-known that an acute load of glucose causes a tran-
sient calciuria rise in normal subjects and to an even greater
degree in idiopathic calcium stone formers and their relatives
(43). Some investigators have conjectured that this effect is
mediated by insulin reducing the tubular reabsorption of calci-
um (44), but others refute this theory because, after comparing
a diet with a high carbohydrate content (60% carbohydrates
and 25% fat) with an isocaloric high-fat diet (50% fat, 35% car-
bohydrates), they did not find any differences in calcium excre-
tion, despite the higher levels of insulin in the subjects on the
higher carbohydrate diet (45). However, the comparison be-
tween diets with low (220 g), medium (450 g) and high (600 g)
carbohydrate content, but unvaried in the content of proteins,
fats and calcium, showed the level of urinary calcium to in-
crease in proportion to the amount of carbohydrate intake (46).
Moreover, optimal metabolic control in diabetic patients
through insulin therapy leads to a considerable decrease in cal-
cium excretion (47).
Surprisingly, after these early reports there have been no fur-
ther studies published on the relationship between carbohy-
drates and calcium stone disease. Rather, interest has shifted
to the relationship between metabolic syndrome, type 2 dia-
betes, insulin resistance and uric acid stone disease. The as-
sociation between body size and risk of kidney stones was not-
ed for the first time in 1998, and has recently been confirmed in
both males and females (48). It is believed that insulin resis-
tance, frequently associated with excess body weight, can alter
the urine acidification mechanism. It has been established for
some time now that gouty patients and uric acid stone formers
in general stand out from the rest of the normal population and
from calcium oxalate stone formers because they have a par-
ticularly acid urine pH, lower than 5.5, which leads to a marked
increase in the undissociated form of uric acid which precipi-
tates in urine (49).
The relation between glucose intolerance and uric acid stones
have been thoroughly investigated. Some authors found that
uric acid stone formers have a high incidence of type 2 dia-
betes or glucose intolerance (50-52). These patients often
show an increased urinary acidity due to a reduced capacity to
eliminate the acid load in the form of ammonium (50). The final
result is a higher concentration of free H+ ions (low pH), higher
titrable acidity and often a decrease in citraturia. Interestingly,
stone formers with type 2 diabetes prevalently form uric acid
stones and show a urinary risk profile very similar to that of
gouty patients (51). The authors hypothesized that insulin re-
sistance in type 2 diabetes might impair renal ammoniogenesis
resulting in a low urine pH. In a subsequent study, they further
supported this hypothesis by showing that patients with recur-
ring uric acid stone disease have severe insulin resistance
(52). A further study showed, in a large population of stone for-
mers, that urine pH is strongly inversely associated with body
weight (53).
Therefore, considering the close relationship between carbohy-
drate consumption, insulin resistance, diabetes mellitus and
obesity, the overall results of these studies enables us to con-
clude that excessive consumption of carbohydrates, especially
simple ones, should be considered as a risk factor for renal
stones, even if no prospective randomized trials exist on the re-
al possibility of preventing stone recurrences by imposing a
suitable low glucide, low calorie diet on patients with such char-
acteristics.
The role of fats
Some observations suggest that fats are also implicated in
stone formation. These observations can be briefly summa-
rized as follows: stone formers show a high prevalence of hy-
percholesterolemia (54); high-fat, high-cholesterol diets can in-
duce stone disease in laboratory animals (55); urinary lipids
play a role in the formation of crystals and stones (56); fat in-
take is correlated with oxalate excretion (57), this relationship
being more evident with regard to the dietary content of arachi-
donic acid (58).
Other investigators found high levels of arachidonic acid in the
plasma and membranes of red blood cells of stone formers
(59), probably related to hypercalciuria through an alteration in
transmembrane ionic transport and overproduction of
prostaglandin E2. These data concur with the demonstration
that ω-3 fatty acid supplementation, in the form of eicosapen-
taenoic acid (EPA) or fish oil, can reduce levels of arachidonic
acid in plasma and tissue and this is accompanied by a de-
crease in the excretion of calcium and oxalate, both in humans
(60) and in laboratory animals (61).
However, a recent observational study did not confirm the exis-
tence of an association between fatty acid intake and the de-
velopment of kidney stones (62). Clinical trials testing the effi-
cacy on stone prevention of high doses of ω-3 polyunsaturated
fatty acids in the form of fish oil supplements have never been
performed. 
The role of sodium chloride
An association between salt consumption and calcium stone
formation was first reported in a large cohort study (6), but
some subsequent studies failed to confirm this finding (7, 9). It
should, however, be recognized that it is very difficult to make
reliable estimates of dietary salt intake based on food question-
naires, as attempted in those studies.
A number of interventional studies published since 1959, re-
viewed in 1995 (63), support the notion that salt consumption
invariably increases calcium excretion and, conversely, salt in-
take reduction induces a decrease in calciuria. From these
studies it can be estimated that an average increase of 100
mmol of salt (approx. 6 g of sodium chloride) generates an av-
erage increase in calciuria equivalent to 1 mmol of calcium (40
mg) in normal adults and 2 mmol (80 mg) in hypercalciuric
stone formers. These findings have important practical implica-
tions if we consider that in some countries the average con-
sumption of salt is at least 10-12 g/day.
Another relevant observation is that the calciuric effect of sodi-
um chloride is additive to that of the proteins as shown by an
experiment performed in normal subjects who increased their
salt intake from 8 g to 12 g and their protein intake from 1 to 2
g/kg (64): calciuria increased by about 50 mg (1.25 mmol) with
each modification and by 100 mg (2.5 mmol) with both modifi-
cations. 
It is important to point out that in literature the term “sodium” is
very often employed as synonymous of salt. This is, however,
misleading because when other types of sodium salts, such as
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sodium bicarbonate and sodium citrate, were compared with
sodium chloride on an equimolar basis, they did not increase
urinary calcium (65, 66), leading to the conclusion that the cal-
ciuria-producing effect of kitchen salt is due to its chloride con-
tent (67).
There is substantial agreement that the salt increases calciuria
through its inhibiting effect on the tubular reabsorption of calci-
um (68).
Additionally, it should also be pointed out that the increase in
sodium chloride in the diet is also accompanied by a significant
decrease in urinary citrate (69), which on its own increases the
lithogenic risk. The mechanism by which salt reduces urinary
citrate is uncertain. According to a widely-shared view, it is re-
lated to the bicarbonaturic effect of the salt intake elicited by
extracellular volume expansion causing a decrease in the ex-
tracellular pH.
Although there are no randomized studies testing the capacity
of a low salt diet to reduce kidney stone formation on its own,
there is evidence suggesting that a low salt intake may improve
the beneficial effects of a low animal protein intake (42).
A balanced diet for the prevention of renal stones should con-
tain no more than 6 g/day of sodium chloride, an amount also
fulfilling the recommendations provided in the updated report of
the Joint National Committee on Prevention, Detection, Evalua-
tion and Treatment of High Blood Pressure (70). To this end, it
is important to inform the patient about the “hidden sources” of
salt.
The role of milk and dairy products
The recommended daily intake of calcium can be satisfied by
foods such as milk (approx. 120 mg per 100 ml), yogurt (ap-
prox. 120 mg per 100 g) and cheese (on average approx. 700
mg per 100 g). Abstaining from such foods leads to a very low-
calcium intake (approx. 400 mg/day).
Calcium intake affects calciuria: in normal subjects an increase
in calcium intake brings about an increase in calciuria equiva-
lent to 8% of the increased amount, rising to 20% in hypercalci-
uric stone formers due to their peculiar ability to hyperabsorb
intestinal calcium (71). This means, for example, that changing
from a diet containing 400 mg of calcium to one containing
1200 mg, can increase calcium excretion in a normal subject
from 120 mg/day to 180 mg/day, and in a hypercalciuric sub-
ject from 240 mg/day to 400 mg/day. This is the reason why,
for many years now, physicians have been advising patients
with calcium stone disease to reduce or eliminate their intake
of milk and dairy products. In the light of current knowledge,
this indication does not appear to be sound for three important
reasons.
Firstly, the low calcium diet may not succeed in reducing calci-
uria in a large percentage of subjects (72), while it can cause a
negative calcium balance (72) which, over prolonged periods,
can lead to the onset of osteopenia/osteoporosis (73).
Secondly, reducing calcium intake increases intestinal absorp-
tion of oxalate (74,75). Oxalate is prevalently absorbed in the
small intestine and colon, where, in the presence of high calci-
um concentration, it can form non absorbable calcium oxalate
salt; conversely, if calcium level in this site is low, the oxalate
will be more easily absorbed in the form of sodium or potassi-
um oxalate. It has been estimated that oxalate excretion de-
creases by an average of 1.9 mg (0.02 mmol) for each 100 mg
increase of calcium intake per day (76). For instance, a change
in daily calcium intake from 400 mg to 1200 mg brings about a
decrease in oxalate excretion from 40 mg/day to 24 mg/day.
The oxalate decrease of 16 mg/day might appear trivial when
compared with the concurrent increase in calciuria, which ac-
cording to the example previously reported, should amount to
60 mg/day in the normocalciuric stone former, and as much as
160 mg/day in the hypercalciuric stone former with a specific
hypersensitivity to calcium intake. However, viewed in terms of
urine supersaturation, the implication of the changes in oxalate
excretion are anything but trivial: changing from the low calci-
um diet to a normal calcium diet does not increase calcium ox-
alate supersaturation, but actually reduces it by approx. 10%.
Thirdly, when we recommend the dietary limitation of milk and
dairy products, patients are likely to increase their animal pro-
tein intake in the form of meat, fish and poultry, leading to all
the potential unfavorable consequences mentioned earlier.
The pathophysiological considerations reported so far agree
with the results achieved in large follow-up studies (6-9). Ac-
cording to these studies, the risk of becoming a stone former,
for men and women alike, is much lower in those who habitual-
ly consume relatively high quantities of calcium (> 1000
mg/day) than in those who consume lower quantities (< 600
mg/day). Finally, a 5-year randomized study conducted on
male hypercalciuric calcium stone formers showed that a low
calcium diet, achieved through the elimination of milk and dairy
products, is less efficacious in the prevention of stone recur-
rences than a normal-calcium, low-animal protein, low-salt diet
(42).
In conclusion, in the light of current knowledge, idiopathic stone
formers should not be deprived of normal quantities of milk and
dairy products.
The role of fruit and vegetables
Doctors are hesitant in advising stone formers to eat fruit and
vegetables, because these foods are the most important di-
etary source of oxalate, part of which is undoubtedly absorbed
to be excreted with the urine. However, their higher urinary ox-
alate notwithstanding (77), vegetarians show a prevalence of
stone disease about half that of omnivores (32). 
How can we explain this apparent paradox? 
First of all, we must point out that only a few vegetables have
demonstrated to significantly increase oxaluria: spinach,
rhubarb, beets, nuts, chocolate, tea, wheat bran and strawber-
ries (78). 
Although a sizable proportion of urinary oxalate may derive
from diet, up to 50% (79), there is great variability from person
to person in intestinal absorption rate. Since about 8-10% of id-
iopathic stone formers show hyperoxaluria (80) and 20-30% of
these show intestinal oxalate hyperabsorption (81), we can
reasonably assume that the problem of oxalate hyperabsorp-
tion should affect no more than 2-3% of idiopathic stone form-
ers.
In the great majority of cases oxalate absorption rate is rather
low, about 6% with the usual dietary intake (79, 81), a propor-
tion rising very little with the higher intakes due to the flattening
of the absorption process (79, 82). Hence, important variations
in intake, namely from 50 mg/day to 250 mg/day, as it may oc-
cur with a free diet, causes the oxaluria to usually increase 4-5
mg/day only (79). Perhaps this is due to the saturation of the
transporters or to the supersaturation of calcium oxalate rising
to such a level in the intestinal lumen as to cause the crystal-
lization of this salt hindering its absorption. 
Finally, as already mentioned previously, the absorption of di-
etary oxalate is strongly affected by the simultaneous dietary
intake of calcium (74, 76). Some Authors have shown that
even hyperoxaluria brought about by a high consumption of ox-
alate-rich foods can be reduced by the simultaneous consump-
tion of milk and dairy products (83, 84).
On the other hand, fruit and vegetables display an antilithogen-
ic effect. 
In general, fruit and vegetables have a low content in protein
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and sodium chloride, a high content in potassium and magne-
sium, and a moderate alkalinizing potential deriving from an-
ions such as bicarbonate and citrate. This peculiar composition
may explain some favorable effects of fruit and vegetables on
some of the most important urinary stone risk factors. It has
been shown that high potassium intake, inherent in the large
consumption of fruit and vegetables, is associated with a re-
duced stone risk (6-9). It has also been shown that these foods
can increase citrate excretion in patients with idiopathic calci-
um stone disease, up to curing conditions of pronounced
hypocitraturia in some cases (24, 25, 85). Moreover, they can
increase the excretion of magnesium (85), another calcium
crystallization inhibitor, and they can decrease calcium excre-
tion (86). Finally, they can increase the urine pH (85, 87) with
favorable effects on the solubility of uric acid.
By converse, the elimination of fruit and vegetables from the di-
et of normal subjects causes unfavourable changes in stone
risk due to the significant increase in the supersaturation for
calcium oxalate and calcium phosphate (85).
Give the above considerations, we encourage physicians to
advise their patients to consume fruit and vegetables regularly,
regardless if they are calcium or uric acid stone formers, pro-
vided that they exercise moderation in the consumption of
foods known to elicit a marked hyperoxaluric effect.
The role of vitamins
The vitamins most implicated in stone risk are vitamin D (cal-
citriol), vitamin C (ascorbic acid) and vitamin B6 (pyridoxine).
A recent follow-up study did not find any association between
vitamin D intake and stone risk (9). It has been known for many
years, however, that some idiopathic hypercalciuric subjects
have an excess of calcitriol in the blood or, in any case, an
overregulation of its receptors, leading to hyperabsorption of in-
testinal calcium (88). Except in special cases, therefore, it is
not advisable to give vitamin D supplements to stone formers,
especially in association with pharmacological calcium supple-
ments.
Vitamin C supplementation is a widespread practice due to its
alleged preventive action against tumors and degenerative dis-
eases. Being a precursor of oxalate and potentially capable of
increasing oxaluria, vitamin C taken in excessive amount could
be dangerous in nephrolithiasis. Truly (89-100), high intakes of
ascorbic acid causes a rise in oxaluria, but of up to 1500
mg/day this effect is negligible and does not increases the risk
of kidney stone (101, 102).
Pyridoxine enters the oxalic acid metabolism and a deficiency
of this vitamin could lead to an increase in the endogenous
production of oxalate (103). On the other hand, supplementa-
tion of pyridoxine in the diet can reduce oxaluria (104).
A high vitamin B6 intake (over 40 mg/day) was associated with
a reduced risk of stones in women (102) but not in men (101).
To sum up, as regards vitamins, a diet designed to prevent
stone disease should avoid excessive intake of vitamin C, sup-
plements of vitamin D and permit the consumption of the rec-
ommended levels of vitamin B6. 
Practical recommendations 
In a nutshell, the recommendations we can made, in the light of
current knowledge, with a view to drawing up an “antilithogenic
diet” both for calcium and for uric acid stone disease, are as
follows.
1. Advise patients to get their body weight down as near as
possible to ideal body weight, by following a low calories diet
as per the instructions below.
2. Advise patients to drink enough water to bring the urinary
volume up to at least 2 liters /day. It is extremely important to
instruct patients to drink the water a little at a time, and to con-
sume a water load of approx. 500 ml before going to bed. An-
other essential aspect is to show patients how to measure uri-
nary volume by themselves periodically, e.g. once a month.
Other fluids may be consumed but not in substitution of water.
If the patient consumes regular quantities of milk and dairy
products, the water should not contain high quantities of calci-
um, e.g. not more than 100 mg/L, in order to avoid excessive
calcium loads, especially between meals.
3. Advise patients to limit animal protein intake, by reducing
above all the consumption of meat and its derivatives; the total
of proteins deriving from meat, fish, chicken, eggs, milk and
cheese should not exceed 50-60 g/day.
4. Advise patients to avoid excessive carbohydrates. Refined
ones, in particular, should not exceed 20 g per day. It might be
useful to replace sucrose with sweeteners such as saccharine
or aspartame.
5. Advise patients to avoid excess of saturated fats, shifting the
calorie requirement to foods rich in omega-3 fatty acids, such
as olive oil, anchovies, sardines and mackerel.
6. Advise patients to limit sodium chloride consumption to no
more than 6 g/day. To this end, it is extremely important for pa-
tients to be aware of the “hidden sources” of salt and to avoid
the use of mixed prepacked foods which tend to be very salty.
7. Advise patients to consume milk, yogurt and cheese regular-
ly, but not excessively and to avoid cheeses containing large
quantities of sodium chloride.
8. Advise patients to consume fruit and vegetables daily, taking
care to avoid foods containing very high quantities of oxalate.
9. Do not give patients vitamin D supplements; allow, if re-
quested, vitamin C supplements of not more than 1500 mg/
day; avoid vitamin B6 deficiencies.
10. Advise patients to use, as far as possible, fresh or frozen
products, not prepacked or precooked foods. If this is not pos-
sible advise them to purchase products bearing a label on
which the content of sodium chloride and other nutrients are
listed.
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